An overview on performance and image enhancing drugs (PIEDs) confiscated in Italy in the period 2017–2019

References

• Baker JS, Graham MR, Davies B. Steroid and prescription medicine abuse in the health and fitness community: a regional study. Eur J Intern Med. 2006;17(7):479–484.
   PubMed Web of Science ®Google Scholar
• Cohen J, Collins R, Darkes J, et al. A league of their own: demographics, motivations and patterns of use of 1,955 male adult non-medical anabolic steroid users in the United States. J Int Soc Sports Nutr. 2007;4:12.
   PubMed Web of Science ®Google Scholar
• Brennan R, Wells JSG, Van Hout MC. The injecting use of image and performance-enhancing drugs (IPED) in the general population: a systematic review. Health Soc Care Community. 2017;25(5):1459–1531.
   PubMed Web of Science ®Google Scholar
• Neves DB, da J, Caldas ED. GC–MS quantitative analysis of black market pharmaceutical products containing anabolic androgenic steroids seized by the Brazilian Federal Police. Forensic Sci Int. 2017;275:272–281.
   PubMed Web of Science ®Google Scholar
• Cho SH, Park HJ, Lee JH, et al. Determination of anabolic-androgenic steroid adulterants in counterfeit drugs by UHPLC-MS/MS. J Pharm Biomed Anal. 2015;111:138–146.
   PubMed Web of Science ®Google Scholar
• Salinas M, Floodgate W, Ralphs R. Polydrug use and polydrug markets amongst image and performance enhancing drug users: implications for harm reduction interventions and drug policy. Int J Drug Policy. 2019;67:43–51.
   PubMed Web of Science ®Google Scholar
• Botrè F, Pavan A. Enhancement drugs and the athlete. Phys Med Rehabil Clin N Am. 2009;20(1):133–148.
   PubMed Web of Science ®Google Scholar
• Bonetti A, Tirelli F, Catapano A, et al. Side effects of anabolic androgenic steroids abuse. Int J Sports Med. 2008;29(08):679–687.
   PubMed Web of Science ®Google Scholar
• Montisci M, El Mazloum R, Cecchetto G, et al. Anabolic androgenic steroids abuse and cardiac death in athletes: morphological and toxicological findings in four fatal cases. Forensic Sci Int. 2012;217(1–3):e13–e18.
   PubMed Web of Science ®Google Scholar
• Niedfeldt MW. Anabolic steroid effect on the liver. Curr Sports Med Rep. 2018;17(3):97–102.
   PubMed Web of Science ®Google Scholar
• Goldman AL, Pope HG, Bhasin S. The health threat posed by the hidden epidemic of anabolic steroid use and body image disorders among young men. J Clin Endocrinol Metab. 2019;104(4):1069–1074.
   PubMed Web of Science ®Google Scholar
• Coomber R, Pavlidis A, Santos GH, et al. The supply of steroids and other performance and image enhancing drugs (PIEDs) in one English city: fakes, counterfeits, supplier trust, common beliefs and access. Perform Enhanc Heal. 2014;3(3–4):135–144.
   Google Scholar
• Krug O, Thomas A, Walpurgis K, et al. Identification of black market products and potential doping agents in Germany 2010-2013. Eur J Clin Pharmacol. 2014;70(11):1303–1311.
   PubMed Web of Science ®Google Scholar
• Temerdashev AZ, Azaryan AA, Labutin AV, et al. Application of chromatography–mass spectrometry methods to the control of sport nutrition and medicines marketed via internet. J Anal Chem. 2017;72(11):1184–1192.
   Web of Science ®Google Scholar
• Paoli L, and Donati, A, 2014. The (illegal) suppliers of doping products BT. In: Paoli L, Donati A, editor. The sports doping market: understanding supply and demand, and the challenges of their control. New York (NY): Springer; p. 59–84.
   Google Scholar
• Romolo FS, Salvini A, Zelaschi F, et al. Instrumental neutron activation analysis (INAA) and liquid chromatography (LC) coupled to high resolution mass spectrometry (HRMS) characterisation of sildenafil based products seized on the Italian illegal market. Forensic Sci Int Synerg. 2019;1:126–136.
   PubMedGoogle Scholar
• Martínez-Sanz JM, Sospedra I, Ortiz CM, et al. Intended or unintended doping? A review of the presence of doping substances in dietary supplements used in sports. Nutrients. 2017;9(10):1093.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency [Internet]. Amsterdam (The Netherlands); [cited 2020 May 4]. https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/falsified-medicines-overview
   Google Scholar
• World Health Organization [Internet]. Geneva (Switzerland): WHO; WHO Global Surveillance and Monitoring System for substandard and falsified medical products; 2017. [cited 2020 May 4] https://www.who.int/medicines/regulation/ssffc/publications/GSMS_ExecutiveSummary_EN.pdf?ua=1
   Google Scholar
• Thevis M, Schrader Y, Thomas A, et al. Analysis of confiscated black market drugs using chromatographic and mass spectrometric approaches. J Anal Toxicol. 2008;32(3):232–240.
   PubMed Web of Science ®Google Scholar
• Graham MR, Ryan P, Baker JS, et al. Counterfeiting in performance- and image-enhancing drugs. Drug Test Anal. 2009;1(3):134–142.
   Web of Science ®Google Scholar
• Hullstein IR, Malerod-Fjeld H, Dehnes Y, et al. Black market products confiscated in Norway 2011-2014 compared to analytical findings in urine samples. Drug Test Anal. 2015;7(11–12):1025–1029.
   PubMed Web of Science ®Google Scholar
• Strano Rossi S, Odoardi S, Gregori A, et al. An analytical approach to the forensic identification of different classes of new psychoactive substances (NPSs) in seized materials. Rapid Commun Mass Spectrom. 2014;28(17):1904–1916.
   PubMed Web of Science ®Google Scholar
• Odoardi S, Castrignanò E, Martello S, et al. Determination of anabolic agents in dietary supplements by liquid chromatography-high-resolution mass spectrometry. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2015;32(5):635–647.
   PubMed Web of Science ®Google Scholar
• Strano-Rossi S, Odoardi S, Castrignanò E, et al. Liquid chromatography-high resolution mass spectrometry (LC-HRMS) determination of stimulants, anorectic drugs and phosphodiesterase 5 inhibitors (PDE5I) in food supplements. J Pharm Biomed Anal. 2015;106:144–152.
   PubMed Web of Science ®Google Scholar
• Jackson G, Montorsi P, Cheitlin MD. Cardiovascular safety of sildenafil citrate (Viagra): an updated perspective. Urology. 2006;68(3):47–60.
   PubMed Web of Science ®Google Scholar
• Habbema L, Halk AB, Neumann M, et al. Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues: a review. Int J Dermatol. 2017;56(10):975–980.
   PubMed Web of Science ®Google Scholar
• Ong S, Bowling J. Melanotan-associated melanoma in situ. Australas J Dermatol. 2012;53(4):301–302.
   PubMed Web of Science ®Google Scholar
• Casella M, Dello Russo A, Izzo G, et al. Ventricular arrhythmias induced by long-term use of ephedrine in two competitive athletes. Heart Vessels. 2015;30(2):280–283.
   PubMed Web of Science ®Google Scholar